Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis. - Wikidata - wikimedia - TriplyDB

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

http://www.wikidata.org/entity/Q35963767

about

HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.HER2-positive gastric cancer.HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives.Investigational therapies targeting the ErbB family in oesophagogastric cancer.Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.Metachronous Liver Metastasis Resulting from Early Gastric Carcinoma after Subtotal Gastrectomy Following Endoscopic Resection: A Case Report.(18)F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value.Clinical significance and positive correlation of FoxM1 and Her-2 expression in gastric cancer.Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study.Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis.HER2 protein expression and HER2 gene amplification are infrequent in small intestinal carcinomas.Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature.Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers.New guidelines for HER2 pathological diagnostics in gastric cancer.HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana.Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia.Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer.Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population

P2860

Q26780318-12A51587-EC23-461E-92AE-93D863F5E81B Q26796280-07805CAC-AFD0-46D4-A9FD-24DD29C43D82 Q36317603-FAB606E5-9976-47B6-B010-ABBE8BC9D861 Q36770491-0830F7F9-AB84-4EB2-8B94-649CBD130AE2 Q37468290-1588EFEA-7F53-4980-8255-454DD5F50DD4 Q37708897-1A8544B5-04F3-4779-8C35-A532AE9C5A50 Q38221886-90205240-252D-4B73-AF93-35E4D1056339 Q40135743-3CEF726C-CA86-4163-A9C5-353DE14B39B9 Q41202740-00C707B4-7979-4402-BE00-D0989D6A7844 Q41835781-AFB6BD15-2DCC-46BF-ADB3-CC92768A20EA Q44530150-3DF4252F-EBC3-47DD-B7FB-7C8E04D4A147 Q47218550-44407CE3-09F7-4156-80D0-50A025F5EE98 Q47425148-DB85DE14-F0FC-436A-8DF3-C585B7CD42DD Q47764668-8C494C6B-E20E-4B03-917D-648CF2AC1B2A Q50964844-6446D4A1-3ABE-4658-B1C1-CE88254F23C3 Q53134672-F02ACF0E-9C07-4C25-8C65-3B54B7009445 Q53424338-873FFAC9-B68D-4273-A9D1-B9E2C5E701C9 Q54219250-3C26DD42-9625-4ED2-96BE-6B3CA8A368A7 Q55030120-F9B0D70E-A16A-47EB-AFB8-7C0D5094D28B Q55175195-E9412313-44F7-4CA8-988C-A81A424A9A72 Q55505567-626DCE08-52A9-495A-8576-8C3099A9E16B Q58774120-57A3DAA7-BBBB-4AE5-B71A-DE862EBC1EB5

P2860

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

http://www.wikidata.org/entity/Q35963767

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

@ast

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

@en

type

label

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

@ast

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

@en

prefLabel

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

@ast

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

@en

P1433

Q35963767-0ED7EE1F-5747-4A7D-B270-2D85BC93203D

P1476

Q35963767-C1B2CDA3-FCEE-439D-B5D1-645B10C091AE

P2093

Q35963767-46B98EE2-3839-40EB-A457-28E0BAE9C674

Q35963767-B5DD3685-AB5A-4FF1-995E-4B3B03E0DD77

Q35963767-FE7CBEBF-6A59-4769-87C9-A15FC9658DFE

P2860

Q35963767-017F7053-34F3-4CEA-AC83-1DC2EACEF276

Q35963767-01F8CEFC-6B3D-451C-BEB5-775E5232BF01

Q35963767-1541A445-E2EE-4425-AE96-1D951F5C946F

Q35963767-333E7863-B973-4334-9DAB-D4F826632569

Q35963767-5865E68F-AC71-4FD0-96DD-2B0679B2AB60

Q35963767-5FC1432D-E582-4D23-AF28-D7D230F57925

Q35963767-674C72EB-6D14-4A69-AEBE-18F4DB0A70BC

Q35963767-68706261-EF7B-462A-BD26-0D79B57F32AA

Q35963767-79E1CAB5-5AF7-423D-B93C-2175F23BF927

Q35963767-C394DF96-6E7C-44D4-A229-5F5A72196501

P304

Q35963767-FB027052-1834-47CF-8080-2783BA0EF022

P31

Q35963767-16E30D3E-7434-44E7-8FDB-02D53FF3B30B

P356

Q35963767-E93D5ABB-A218-4BA6-A9FA-6A11CF168A1C

P407

Q35963767-8B4D647C-CD91-4AF3-9039-FA064702A354

P433

Q35963767-6E253436-05EF-4C5E-B890-EA57879EA919

P478

Q35963767-8B37E851-D588-4B62-8EE6-9D5EA155263A

P577

Q35963767-27C89BFF-CE23-4F36-B464-6943624EB933

P5875

Q35963767-F989426B-D5FE-48D3-BB6E-5FA188575B16

P698

Q35963767-A8ABD6A6-463E-416E-ABD8-5552F16BFB84

P932

Q35963767-DDC77109-827D-4480-A1CC-09C50ED70120

P356

WJG.V18.I19.2402

P1433

World Journal of Gastroenterology

P1476

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

@en

P2093

Hai-Zhen Dang

http://www.w3.org/2001/XMLSchema#string

Shun-Chang Jiao

http://www.w3.org/2001/XMLSchema#string

Yang Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.

Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies

Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.

Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.

Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.

The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.

Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer.

Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance.

Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.

P304

2402-2407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V18.I19.2402

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225086654

http://www.w3.org/2001/XMLSchema#string

P698

22654433

http://www.w3.org/2001/XMLSchema#string

P932

3353376

http://www.w3.org/2001/XMLSchema#string